ACCESSWIRE
United States
Tel: 1-888-952-4446
Website: https://www.accesswire.com/
Email: DigitalSales@accesswire.com
About ACCESSWIRE
ACCESSWIRE is a global newswire and communications network, delivering regional, national and international news to thousands of customers across the world. ACCESSWIRE serves both public and private companies, disseminating their full-text and rich media press releases to news media, financial markets, investors, information websites, databases, bloggers and social networks.
The press release platform offers an exceptionally cost-effective Fair Disclosure, Regulation FD news dissemination and media outreach service.
Platform users can easily publish rich media assets, such as video, audio and images, and build their own distribution to the most-needed outlets. Users can effectively distribute an earnings announcement, product launch, community message, M&A transaction or corporate update to the worldwide news network.
Corporate issuers and their constituents find the cloud-based platforms and related services particularly robust — from document creation through dissemination to regulatory bodies, platforms and shareholders.
Contact ACCESSWIRE’s parent company, Issuer Direct, to learn more.
5969 articles about ACCESSWIRE
-
Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities
5/16/2022
Aytu BioPharma, Inc., a pharmaceutical company focused on developing and commercializing novel therapeutics, reported financial results for its fiscal 2022 third quarter, ended March 31, 2022 and outlined its key strategic priorities.
-
NeoGenomics Appoints Lynn Tetrault Interim CEO
5/16/2022
NeoGenomics, Inc. a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced the appointment of Lynn Tetrault, Esq., the current Executive Chair and Principal Executive Officer, as Chair of the Board and Interim CEO as of May 12, 2022.
-
Hemogenyx Pharmaceuticals PLC Announces Immuno-Oncology Summit Europe Presentation
5/16/2022
Hemogenyx Pharmaceuticals plc is pleased to announce its participation in the Immuno-Oncology Summit Europe 2022, at which Dr Vladislav Sandler will make a presentation entitled "Anti-FLT3 CAR-T and Bispecific Antibody Therapies for Effective Elimination of AML and Conditioning for Hematopoietic Stem Cell Transplantation".
-
Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates
5/16/2022
Celcuity Inc., a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, announced financial results for the first quarter ended March 31, 2022 and other recent business progress.
-
Celcuity Inc. Announces $100 Million Private Placement
5/16/2022
Celcuity Inc. (Nasdaq:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that it has entered into a definitive securities purchase agreement with certain institutional and other accredited investors in a private placement for the purchase of common stock.
-
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
5/16/2022
Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced a key opinion leader (KOL) presentation and a live-case event featuring the Company's Lumivascular technology at two important vascular conferences in Germany.
-
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022
5/16/2022
9 Meters Biopharma, Inc. (Nasdaq:NMTR), a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, today provided an overview of its recent achievements, important upcoming milestones, and financial results for the first quarter ended March 31, 2022.
-
StageZero Life Sciences Launches COC Plus Worldwide
5/15/2022
StageZero Life Sciences, Ltd. announced the worldwide launch of the COC Plus Program for patients currently in the COC Protocol / TREAT Program.
-
Edesa Biotech Reports Fiscal 2nd Quarter 2022 Results
5/13/2022
Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2022 and provided an update on its business.
-
StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17
5/13/2022
StageZero Life Sciences announced that it will release its first quarter financial results before the market open on Tuesday May 17, 2022.
-
Artelo Biosciences to Present at MicroCap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th
5/13/2022
Artelo Biosciences, Inc. announced that Gregory D. Gorgas, Chief Executive Officer of Artelo has been invited to present at the Spring Into Action - Best Ideas Virtual Investor Conference, which is being held virtually May 16th - 20th, 2022.
-
Scientific Industries to Report Third Quarter Fiscal Year 2022 Financial Results on May 16, 2022
5/13/2022
Scientific Industries, Inc., a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will file a Form 10Q for its financial results for the period ended March 31, 2022, after the market close on Monday, May 16, 2022.
-
ONT Chosen for Comprehensive Human Genome Program
5/13/2022
Oxford Nanopore sequencing technology is to be used by a group of researchers led by Evan Eichler, University of Washington and Danny Miller, University of Washington and Seattle Children's Hospital, to initially sequence 500 of the 1000 Genomes Project samples.
-
Invitation to Conference Call Regarding Promore Pharma’s Interim Report for the First Quarter 2022
5/13/2022
Promore Pharma AB publishes its interim report for the first quarter 2022 on 17 May 2022.
-
Reimbursement Established for Lung and Liver Transplant in the Netherlands Based on Results from Clinical Trials with XVIVO's Leading Technologies
5/12/2022
Machine perfusion for lungs and livers is now being reimbursed in the Dutch healthcare system.
-
Biophytis: Biophytis Announces its Participation at the BIO International Convention in San Diego from the 13th to the 16th of June 2022
5/12/2022
Biophytis SA announces it will participate, represented by its CEO Stanislas Veillet and its Business Development Director Benoit Canolle, at the Biotechnology Innovation Organization International Convention to be held in San Diego from the 13th to the 16th of June 2022, alongside thousands of world leaders in biotechnology and the pharmaceutical industry.
-
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022
5/12/2022
Integrated BioPharma, Inc. reports its financial results for the fiscal quarter ended March 31, 2022.
-
Xenetic Biosciences, Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
5/12/2022
Xenetic Biosciences, Inc. reported its financial results for the first quarter of 2022 and provided a business update.
-
Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
5/12/2022
Aptevo Therapeutics Inc. today reported financial results and business highlights for the quarter ended March 31, 2022.
-
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
5/12/2022
Viveve Medical, Inc. reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET.